Pharmacologic Management of Belching Based on Underlying Mechanism

Mechanism‑Based Pharmacologic Approach

Gastric belching linked to gastro‑esophageal reflux disease (GERD) should be treated initially with proton‑pump inhibitor (PPI) therapy together with lifestyle modifications (e.g., dietary changes, head‑of‑bed elevation)【1】【2】【3】【4】.
PPIs alleviate the acid reflux that can trigger belching episodes【4】.
Fundoplication surgery is reserved for patients with severe, pathologic GERD who remain symptomatic despite optimal medical therapy【1】【2】【3】.
When gastric belching is driven by excessive transient lower esophageal sphincter relaxations (TLESRs), baclofen—a GABA‑B receptor agonist—should be considered【1】【2】【3】【4】.
For supragastric (voluntary) belching, central neuromodulators (e.g., antidepressants) are recommended as adjuncts to brain‑gut behavioral therapies【1】【3】.
Neuromodulators improve symptoms by reducing visceral hypersensitivity, raising sensory thresholds, and addressing psychological comorbidities【5】.
Neuromodulators must be combined with behavioral therapy rather than used as monotherapy for supragastric belching【1】【3】【4】.

Gastric belching occurs less frequently but with greater force compared with supragastric belching【1】【2】【3】【4】.
Ambulatory impedance monitoring ± high‑resolution manometry (minimum 90 min; 24‑hour study preferred) is the recommended method to differentiate the two belching types【1】【2】【3】【4】.
High‑resolution manometry in supragastric belching demonstrates upper esophageal sphincter relaxation with air entering the esophagus and being expelled orally before reaching the stomach【1】【2】【3】【4】.

Gastroparesis should be excluded in patients who present with nausea, vomiting, and belching, as it may require a different pharmacologic strategy【1】【2】【3】【4】.
Rumination disorder must be ruled out using high‑resolution manometry with impedance, because its management differs from that of belching【1】【2】【3】【4】.

Prescribing pharmacologic agents for supragastric belching without concurrent behavioral therapy is a critical error; medications alone do not address the underlying voluntary behavior【1】【2】【3】【4】.
Primary treatment for supragastric belching should be brain‑gut behavioral therapies (e.g., cognitive‑behavioral therapy, diaphragmatic breathing, speech therapy), with neuromodulators used only as adjuncts【1】【2】【3】.